This is a summary of the fourth joint inter-agency report on integrated analysis of antimicrobial consumption and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals in the European Union (JIACRA IV – 2019–2021).
This report provides an integrated analysis of relationships between antimicrobial consumption in humans and food- producing animals and the occurrence of antimicrobial resistance in bacteria from humans and food- producing animals, respectively.
For 2022, 29 European Union/European Economic Area (EU/EEA) countries reported 8 565 confirmed cases of Shiga toxin-producing Escherichia coli (STEC) infection.
In 2022, the first and second most reported zoonoses in humans were campylobacteriosis and salmonellosis, respectively. The number of cases of campylobacteriosis and salmonellosis remained stable in comparison with 2021.
This report presents the results of the 11th round of the external quality assessment (EQA-11) scheme for typing of Shiga toxin-producing Escherichia coli (STEC).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 September 2023 and includes updates on COVID-19, diphtheria, West Nile virus, avian influenza, dengue, legionnaires' disease, the Rugby World Cup 2023, cutaneous Anthrax, pertussis, botulism and severe floods.
Anthrax continues to be uncommon in humans in the EU/EEA, with only a few cases reported every year. For 2021, four confirmed anthrax cases were reported by Bulgaria (one case) and Spain (three cases). Among 30 reporting EU/EEA countries, 27 notified zero cases.
Analysis of whole genome sequencing and epidemiological data of 874 E. coli isolates from the national collections of 13 countries confirmed the increase of E. coli isolates carrying blaNDM-5 which was previously detected in the CCRE survey.